Agency struggled to get pharma companies to engage in drug-price reform

  • 📰 CHEK_News
  • ⏱ Reading Time:
  • 34 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 17%
  • Publisher: 55%

United States News News

United States United States Latest News,United States United States Headlines

Agency struggled to get pharma companies to engage in drug-price reform: memo

Minister of Health Jean-Yves Duclos speaks to reporters on the sidelines of the Liberal Convention in Ottawa, on Friday, May 5, 2023. Health Minister Jean-Yves Duclos was warned that pharmaceutical companies had steadfastly refused to engage on drug-price reforms before he urged an independent federal agency to pause those reforms in favour of more consultation, a 2021 memo shows.

In 2017, the government announced new rules to bring prices down by expanding the number of countries Canada compares with. Those changes were supposed to be introduced in 2020 but were delayed multiple times because of the COVID-19 pandemic before eventually coming into effect last July. “After five years, myriad policy proposals and many hundreds of hours of consultation, it would appear the pharmaceutical industry is simply not amenable to any measures that would further constrain its ability to sell patented medicines in Canada at free market prices,” the acting chair of the agency’s board at the time, Melanie Bourassa Forcier, wrote in the memo.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 59. in US
 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

United States United States Latest News, United States United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Agency struggled to get pharma companies to engage in drug-price reform: memoHealth Minister Jean-Yves Duclos was warned that pharmaceutical companies had steadfastly refused to engage on drug-price reforms before he urged an independent federal agency to pause those reforms in favour of more consultation, a 2021 memo shows.
Source: CTVNews - 🏆 1. / 99 Read more »